Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Serbia to invest in antenatal genetic testing:

This article was originally published in Clinica

Executive Summary

Serbia has earmarked over E2m ($2.6m) for the procurement of diagnostic equipment for detecting genetic abnormalities in the early stages of pregnancy. This follows a donation to the country of E2.5m by the European Agency for Reconstruction (EAR). Current capacities for diagnosing abnormalities antenally meet only one-third of needs, according to Matthias Reinicke, programme manager at EAR. The remaining funding will be used for training.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel